Web: | mayocliniclabs.com |
---|---|
Email: | mcl@mayo.edu |
Telephone: | 800-533-1710 |
International: | +1 855-379-3115 |
Values are valid only on day of printing. |
Risk stratification of patients with multiple myeloma, which can assist in determining treatment and management decisions
Risk stratification of patients with newly diagnosed multiple myeloma
Test ID | Reporting Name | Available Separately | Always Performed |
---|---|---|---|
CSMRT | MPCDS Pre-Analysis Cell Sorting, BM | No | No |
MPCDS | mSMART Eval, PCPDs, FISH | No | No |
Based on the flow cytometric analysis and presence of greater than or equal to 0.1% monotypic plasma cells, the pre-analysis cell sorting and FISH for plasma cell proliferative disorder will be reflexed and performed at an additional charge.
This test is designed for diagnostic specimens. If a request for testing has been submitted within 12 months of a complete and informative plasma cell proliferative disorder FISH study, the current test request will be cancelled.
See Laboratory Screening Tests for Suspected Multiple Myeloma in Special Instructions.
Flow Cytometry/DNA Content/Cell Cycle Analysis